![](/img/cover-not-exists.png)
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2 -Negative Breast Cancer—the Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial
Gianni, Luca, Mansutti, Mauro, Anton, Antonio, Calvo, Lourdes, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chacon, Jose Ignacio, Chan, Arlene, Morales, Serafin, Alvarez, IsLanguage:
english
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2017.4612
Date:
January, 2018
File:
PDF, 355 KB
english, 2018